On the other hand, Moderna Inc (NASDAQ: MRNA) posted a surprise profit and higher than expected revenue following the launch ...
Expects to complete enrollment of the 400-participant sentinel cohort for the COVID-19 Phase 2b study in November 2024 Solid financial position enables Vaxart to attain multiple regulatory and ...
Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.
Hosted on MSN17h
Improved lipid-polymer nanoparticle could advance inhalable mRNA medications and vaccinesMost people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
Most people don’t enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...
A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...
The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback